Health for all, Hunger for none

Explore Your Topic

First-in-class glucokinase activator (GKA) HuaTangNing approved in China

The 7th CIIE Concludes Successfully. Bayer Has Demonstrated Innovative Strengths and Collaborated to Build a Brighter Future

Bayer Participates in CIIE for the 7th Consecutive Time: Showcasing Innovation, Strengthening Cooperation, and Reinforcing Commitment to China

Bayer Helps to Build Consumer Health Product-and-Solution Platform

Bayer increases investment in innovation to promote sustainable development of business in China

November 10, 2024

The 7th CIIE Concludes Successfully. Bayer Has Demonstrated Innovative Strengths and Collaborated to Build a Brighter Future

November 06, 2024

Bayer Co.Lab welcomes Codone Biotechnology as its first resident company in China

November 05, 2024

Bayer Participates in CIIE for the 7th Consecutive Time: Showcasing Innovation, Strengthening Cooperation, and Reinforcing Commitment to China

April 24, 2024

Bayer China Academic Collaboration Award 2023 unveiled

Explore Our Businesses

We address some of the world's most pressing global challenges and continue to develop new solutions. The population is constantly growing and its age is increasing. That is why it needs better medicines and high-quality food in sufficient quantities. Learn more about it here.